Early cyclosporine blood levels impact the incidence of acute rejection and overall mortality in the first year after heart transplantation
Gespeichert in:
| Veröffentlicht in: | Transplantation proceedings 1998-08, Vol.30 (5), p.1671-1672 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1672 |
|---|---|
| container_issue | 5 |
| container_start_page | 1671 |
| container_title | Transplantation proceedings |
| container_volume | 30 |
| creator | Gómez-Sánchez, >M.A Delgado, J.F Escribano, P Santos, M Sotelo, T Gil, R Hernández-Afonso, J Ortuño, B Romero, F Sáenz de la Calzada, C Rodriguez, J.E Rufilanchas, J.J |
| description | |
| doi_str_mv | 10.1016/S0041-1345(98)00386-8 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73869034</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0041134598003868</els_id><sourcerecordid>73869034</sourcerecordid><originalsourceid>FETCH-LOGICAL-c339t-ad43ba9111a686288de0d869454b28401ba5e589c8a76fac4a8daabbc81c61ad3</originalsourceid><addsrcrecordid>eNqFkc1u1DAUhS0EKkPhESp5gRAsAnbsJM4KVVWBSpW6KKytG_tGdeXEwfaMlGfoS-P50WxZ2dY95_jqO4RccfaVM95-e2RM8ooL2Xzu1RfGhGor9YpsuOpEVbe1eE02Z8lb8i6lZ1betRQX5KLvalGLbkNebiH6lZrV-JCWEN2MdPAhWOpxhz5RNy1gMs1PSN1snMXZIA0jBbPNSCM-o8kuzBRmS8MOI3hPpxAzeJfXYjk4RxdTpitCpDBmjPSpXEtohDktHuYM-4z35M0IPuGH03lJ_vy4_X3zq7p_-Hl3c31fGSH6XIGVYoCecw6tamulLDKr2l42cqiVZHyABhvVGwVdO4KRoCzAMBjFTcvBikvy6Zi7xPB3iynrySWDviyCYZt0V1D2TMgibI5CE0NKEUe9RDdBXDVnel-CPpSg94R1r_ShBK2K7-r0wXaY0J5dJ-pl_vE0h2TAjwWDceksKxXVjLMi-36UlR5w5zDqZNyev3WxUNc2uP8s8g9dRqbU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73869034</pqid></control><display><type>article</type><title>Early cyclosporine blood levels impact the incidence of acute rejection and overall mortality in the first year after heart transplantation</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Gómez-Sánchez, >M.A ; Delgado, J.F ; Escribano, P ; Santos, M ; Sotelo, T ; Gil, R ; Hernández-Afonso, J ; Ortuño, B ; Romero, F ; Sáenz de la Calzada, C ; Rodriguez, J.E ; Rufilanchas, J.J</creator><creatorcontrib>Gómez-Sánchez, >M.A ; Delgado, J.F ; Escribano, P ; Santos, M ; Sotelo, T ; Gil, R ; Hernández-Afonso, J ; Ortuño, B ; Romero, F ; Sáenz de la Calzada, C ; Rodriguez, J.E ; Rufilanchas, J.J</creatorcontrib><identifier>ISSN: 0041-1345</identifier><identifier>EISSN: 1873-2623</identifier><identifier>DOI: 10.1016/S0041-1345(98)00386-8</identifier><identifier>PMID: 9723237</identifier><identifier>CODEN: TRPPA8</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Biological and medical sciences ; Cyclosporine - blood ; Cyclosporine - therapeutic use ; Drug Monitoring ; Drug Therapy, Combination ; Female ; Graft Rejection - epidemiology ; Graft Rejection - prevention & control ; Heart Transplantation - immunology ; Heart Transplantation - mortality ; Heart Transplantation - physiology ; Hemodynamics ; Humans ; Immunomodulators ; Immunosuppressive Agents - blood ; Immunosuppressive Agents - therapeutic use ; Incidence ; Male ; Medical sciences ; Methylprednisolone - therapeutic use ; Middle Aged ; Muromonab-CD3 - therapeutic use ; Pharmacology. Drug treatments ; Postoperative Period ; Retrospective Studies ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases ; Surgery of the heart ; Survival Rate ; Time Factors</subject><ispartof>Transplantation proceedings, 1998-08, Vol.30 (5), p.1671-1672</ispartof><rights>1998 Elsevier Science Inc.</rights><rights>1998 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c339t-ad43ba9111a686288de0d869454b28401ba5e589c8a76fac4a8daabbc81c61ad3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0041-1345(98)00386-8$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>309,310,314,780,784,789,790,3550,23930,23931,25140,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2432010$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9723237$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gómez-Sánchez, >M.A</creatorcontrib><creatorcontrib>Delgado, J.F</creatorcontrib><creatorcontrib>Escribano, P</creatorcontrib><creatorcontrib>Santos, M</creatorcontrib><creatorcontrib>Sotelo, T</creatorcontrib><creatorcontrib>Gil, R</creatorcontrib><creatorcontrib>Hernández-Afonso, J</creatorcontrib><creatorcontrib>Ortuño, B</creatorcontrib><creatorcontrib>Romero, F</creatorcontrib><creatorcontrib>Sáenz de la Calzada, C</creatorcontrib><creatorcontrib>Rodriguez, J.E</creatorcontrib><creatorcontrib>Rufilanchas, J.J</creatorcontrib><title>Early cyclosporine blood levels impact the incidence of acute rejection and overall mortality in the first year after heart transplantation</title><title>Transplantation proceedings</title><addtitle>Transplant Proc</addtitle><subject>Biological and medical sciences</subject><subject>Cyclosporine - blood</subject><subject>Cyclosporine - therapeutic use</subject><subject>Drug Monitoring</subject><subject>Drug Therapy, Combination</subject><subject>Female</subject><subject>Graft Rejection - epidemiology</subject><subject>Graft Rejection - prevention & control</subject><subject>Heart Transplantation - immunology</subject><subject>Heart Transplantation - mortality</subject><subject>Heart Transplantation - physiology</subject><subject>Hemodynamics</subject><subject>Humans</subject><subject>Immunomodulators</subject><subject>Immunosuppressive Agents - blood</subject><subject>Immunosuppressive Agents - therapeutic use</subject><subject>Incidence</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Methylprednisolone - therapeutic use</subject><subject>Middle Aged</subject><subject>Muromonab-CD3 - therapeutic use</subject><subject>Pharmacology. Drug treatments</subject><subject>Postoperative Period</subject><subject>Retrospective Studies</subject><subject>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><subject>Surgery of the heart</subject><subject>Survival Rate</subject><subject>Time Factors</subject><issn>0041-1345</issn><issn>1873-2623</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc1u1DAUhS0EKkPhESp5gRAsAnbsJM4KVVWBSpW6KKytG_tGdeXEwfaMlGfoS-P50WxZ2dY95_jqO4RccfaVM95-e2RM8ooL2Xzu1RfGhGor9YpsuOpEVbe1eE02Z8lb8i6lZ1betRQX5KLvalGLbkNebiH6lZrV-JCWEN2MdPAhWOpxhz5RNy1gMs1PSN1snMXZIA0jBbPNSCM-o8kuzBRmS8MOI3hPpxAzeJfXYjk4RxdTpitCpDBmjPSpXEtohDktHuYM-4z35M0IPuGH03lJ_vy4_X3zq7p_-Hl3c31fGSH6XIGVYoCecw6tamulLDKr2l42cqiVZHyABhvVGwVdO4KRoCzAMBjFTcvBikvy6Zi7xPB3iynrySWDviyCYZt0V1D2TMgibI5CE0NKEUe9RDdBXDVnel-CPpSg94R1r_ShBK2K7-r0wXaY0J5dJ-pl_vE0h2TAjwWDceksKxXVjLMi-36UlR5w5zDqZNyev3WxUNc2uP8s8g9dRqbU</recordid><startdate>19980801</startdate><enddate>19980801</enddate><creator>Gómez-Sánchez, >M.A</creator><creator>Delgado, J.F</creator><creator>Escribano, P</creator><creator>Santos, M</creator><creator>Sotelo, T</creator><creator>Gil, R</creator><creator>Hernández-Afonso, J</creator><creator>Ortuño, B</creator><creator>Romero, F</creator><creator>Sáenz de la Calzada, C</creator><creator>Rodriguez, J.E</creator><creator>Rufilanchas, J.J</creator><general>Elsevier Inc</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19980801</creationdate><title>Early cyclosporine blood levels impact the incidence of acute rejection and overall mortality in the first year after heart transplantation</title><author>Gómez-Sánchez, >M.A ; Delgado, J.F ; Escribano, P ; Santos, M ; Sotelo, T ; Gil, R ; Hernández-Afonso, J ; Ortuño, B ; Romero, F ; Sáenz de la Calzada, C ; Rodriguez, J.E ; Rufilanchas, J.J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c339t-ad43ba9111a686288de0d869454b28401ba5e589c8a76fac4a8daabbc81c61ad3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Biological and medical sciences</topic><topic>Cyclosporine - blood</topic><topic>Cyclosporine - therapeutic use</topic><topic>Drug Monitoring</topic><topic>Drug Therapy, Combination</topic><topic>Female</topic><topic>Graft Rejection - epidemiology</topic><topic>Graft Rejection - prevention & control</topic><topic>Heart Transplantation - immunology</topic><topic>Heart Transplantation - mortality</topic><topic>Heart Transplantation - physiology</topic><topic>Hemodynamics</topic><topic>Humans</topic><topic>Immunomodulators</topic><topic>Immunosuppressive Agents - blood</topic><topic>Immunosuppressive Agents - therapeutic use</topic><topic>Incidence</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Methylprednisolone - therapeutic use</topic><topic>Middle Aged</topic><topic>Muromonab-CD3 - therapeutic use</topic><topic>Pharmacology. Drug treatments</topic><topic>Postoperative Period</topic><topic>Retrospective Studies</topic><topic>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</topic><topic>Surgery of the heart</topic><topic>Survival Rate</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gómez-Sánchez, >M.A</creatorcontrib><creatorcontrib>Delgado, J.F</creatorcontrib><creatorcontrib>Escribano, P</creatorcontrib><creatorcontrib>Santos, M</creatorcontrib><creatorcontrib>Sotelo, T</creatorcontrib><creatorcontrib>Gil, R</creatorcontrib><creatorcontrib>Hernández-Afonso, J</creatorcontrib><creatorcontrib>Ortuño, B</creatorcontrib><creatorcontrib>Romero, F</creatorcontrib><creatorcontrib>Sáenz de la Calzada, C</creatorcontrib><creatorcontrib>Rodriguez, J.E</creatorcontrib><creatorcontrib>Rufilanchas, J.J</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Transplantation proceedings</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gómez-Sánchez, >M.A</au><au>Delgado, J.F</au><au>Escribano, P</au><au>Santos, M</au><au>Sotelo, T</au><au>Gil, R</au><au>Hernández-Afonso, J</au><au>Ortuño, B</au><au>Romero, F</au><au>Sáenz de la Calzada, C</au><au>Rodriguez, J.E</au><au>Rufilanchas, J.J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Early cyclosporine blood levels impact the incidence of acute rejection and overall mortality in the first year after heart transplantation</atitle><jtitle>Transplantation proceedings</jtitle><addtitle>Transplant Proc</addtitle><date>1998-08-01</date><risdate>1998</risdate><volume>30</volume><issue>5</issue><spage>1671</spage><epage>1672</epage><pages>1671-1672</pages><issn>0041-1345</issn><eissn>1873-2623</eissn><coden>TRPPA8</coden><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>9723237</pmid><doi>10.1016/S0041-1345(98)00386-8</doi><tpages>2</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0041-1345 |
| ispartof | Transplantation proceedings, 1998-08, Vol.30 (5), p.1671-1672 |
| issn | 0041-1345 1873-2623 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_73869034 |
| source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
| subjects | Biological and medical sciences Cyclosporine - blood Cyclosporine - therapeutic use Drug Monitoring Drug Therapy, Combination Female Graft Rejection - epidemiology Graft Rejection - prevention & control Heart Transplantation - immunology Heart Transplantation - mortality Heart Transplantation - physiology Hemodynamics Humans Immunomodulators Immunosuppressive Agents - blood Immunosuppressive Agents - therapeutic use Incidence Male Medical sciences Methylprednisolone - therapeutic use Middle Aged Muromonab-CD3 - therapeutic use Pharmacology. Drug treatments Postoperative Period Retrospective Studies Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases Surgery of the heart Survival Rate Time Factors |
| title | Early cyclosporine blood levels impact the incidence of acute rejection and overall mortality in the first year after heart transplantation |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T17%3A08%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Early%20cyclosporine%20blood%20levels%20impact%20the%20incidence%20of%20acute%20rejection%20and%20overall%20mortality%20in%20the%20first%20year%20after%20heart%20transplantation&rft.jtitle=Transplantation%20proceedings&rft.au=G%C3%B3mez-S%C3%A1nchez,%20%3EM.A&rft.date=1998-08-01&rft.volume=30&rft.issue=5&rft.spage=1671&rft.epage=1672&rft.pages=1671-1672&rft.issn=0041-1345&rft.eissn=1873-2623&rft.coden=TRPPA8&rft_id=info:doi/10.1016/S0041-1345(98)00386-8&rft_dat=%3Cproquest_cross%3E73869034%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=73869034&rft_id=info:pmid/9723237&rft_els_id=S0041134598003868&rfr_iscdi=true |